
    WARNER CHILCOTT COMPANY, LLC, Warner Chilcott (US), LLC, and Mayne Pharma International Pty. Ltd., Plaintiffs-Appellants, v. IMPAX LABORATORIES, INC., Defendant-Cross Appellant, and Mylan Pharmaceuticals Inc. and Mylan Inc., Defendants-Cross Appellants, and Sandoz, Inc., Defendant.
    Nos. 2012-1376, 2012-1377, 2012-1378, 2012-1440, 2012-1441, 2012-1442.
    United States Court of Appeals, Federal Circuit.
    Sept. 7, 2012.
    Dominick A. Conde, Fitzpatrick, Celia, Harper & Scinto, of New York, NY, argued for plaintiffs-appellants. With him on the brief were Gregory B. Sephton, Diego Scambia, Brendan M. O’Malley, and Jeffrey R. Colin. Of counsel on the brief was John E. Flaherty, McCarter & English, LLP, of Newark, NJ. Of counsel was Christina A.L. Schwarz, Fitzpatrick, Celia, Harper & Scinto, of New York, NY.
    Eric H. Weisblatt, Wiley Rein LLP, of Washington, DC, argued for defendant-cross appellant, Impax Laboratories, Inc. With him on the brief were Mark A. Pacel-la, Robert J. Scheffel, Lucy M. Stark and Adrienne G. Johnson. Of counsel was Michael E. Patunas, Lite DePalma, Green-berg & Rivas, LLC, of Newark, NJ.
    Larry L. Shatzer, Wilson Sonsini Goodrich & Rosati, PC, of Washington, DC, argued for defendants-cross appellants, Mylan Pharmaceuticals Inc., et al. With him on the brief were Shaun R. Snader; and Joshua Mack, of San Diego, CA; and Tung On Kong, of San Francisco, CA. Of counsel on the brief was Arnold B. Cal-mann, Saiber, LLC, of Newark, NJ.
    Before RADER, Chief Judge, DYK and O’MALLEY, Circuit Judges.
   JUDGMENT

PER CURIAM.

THIS CAUSE having been heard and considered, it is

Ordeeed and Adjudged.-

AFFIRMED. See Fed. Cir. R. 36.  